Related Experiment Video
Updated: Mar 6, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
Mechanisms of kinetic stabilization by the drugs paclitaxel and vinblastine
Brian T Castle1, Seth McCubbin2, Louis S Prahl1
1Department of Biomedical Engineering, University of Minnesota, Minneapolis, MN 55455.
Abstract:
Microtubule-targeting agents (MTAs), widely used as biological probes and chemotherapeutic drugs, bind directly to tubulin subunits and "kinetically stabilize" microtubules, suppressing the characteristic self-assembly process of dynamic instability. However, the molecular-level mechanisms of kinetic stabilization are unclear, and the fundamental thermodynamic and kinetic requirements for dynamic instability and its elimination by MTAs have yet to be defined. Here we integrate a computational model for microtubule assembly with nanometer-scale fluorescence microscopy measurements to identify the kinetic and thermodynamic basis of kinetic stabilization by the MTAs paclitaxel, an assembly promoter, and vinblastine, a disassembly promoter. We identify two distinct modes of kinetic stabilization in live cells, one that truly suppresses on-off kinetics, characteristic of vinblastine, and the other a "pseudo" kinetic stabilization, characteristic of paclitaxel, that nearly eliminates the energy difference between the GTP- and GDP-tubulin thermodynamic states. By either mechanism, the main effect of both MTAs is to effectively stabilize the microtubule against disassembly in the absence of a robust GTP cap.
Insights
Microtubule-targeting agents (MTAs) stabilize microtubules through two distinct mechanisms. This research clarifies how MTAs like paclitaxel and vinblastine affect microtubule dynamics, crucial for cancer drug development.
Area of Science:
- Cell Biology
- Biochemistry
- Pharmacology
Background:
- Microtubule-targeting agents (MTAs) are vital chemotherapeutics and biological probes.
- MTAs function by binding tubulin and kinetically stabilizing microtubules, inhibiting dynamic instability.
- The precise molecular mechanisms and thermodynamic/kinetic underpinnings of MTA-induced kinetic stabilization remain incompletely understood.
Purpose of the Study:
- To elucidate the kinetic and thermodynamic basis of kinetic stabilization induced by paclitaxel and vinblastine.
- To differentiate the mechanisms of kinetic stabilization employed by assembly-promoting (paclitaxel) and disassembly-promoting (vinblastine) MTAs.
- To define the fundamental requirements for microtubule dynamic instability and its suppression by MTAs.
Main Methods:
- Integration of a computational model for microtubule assembly.
- Application of nanometer-scale fluorescence microscopy in live cells.
- Analysis of kinetic and thermodynamic parameters governing tubulin dynamics.
Main Results:
- Identified two distinct modes of kinetic stabilization by MTAs in live cells.
- Vinblastine exhibits true kinetic stabilization by suppressing on-off kinetics.
- Paclitaxel demonstrates "pseudo" kinetic stabilization by reducing the GTP- and GDP-tubulin energy difference.
- Both MTAs effectively stabilize microtubules against disassembly, particularly without a GTP cap.
Conclusions:
- The study clarifies the distinct molecular mechanisms underlying kinetic stabilization by different classes of MTAs.
- Understanding these mechanisms provides insight into microtubule dynamics and MTA efficacy.
- Findings contribute to the rational design of novel chemotherapeutic agents targeting microtubule dynamics.
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Destabilization of Microtubules
Targeted Cancer Therapies
There are several types of targeted therapies against...
Inhibition of Cdk Activity
DNA Damage can Stall the Cell Cycle

